Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.860
-0.020 (-0.41%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $15.87 million as of August 21, 2026. Its market cap has increased by 12.40% in one year.
Market Cap
15.87M
Enterprise Value
6.43M
1-Year Change
12.40%
Ranking
Category
Stock Price
$4.86
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $15.87M, a decrease of -75.96%. That is a compound annual growth rate of -36.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 15.87M | -35.60% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 17.23M |
| Tempest Therapeutics | 16.62M |
| Psyence Biomedical | 16.52M |
| Citius Pharmaceuticals | 16.48M |
| Vyome Holdings | 15.79M |
| Chemomab Therapeutics | 15.65M |
| BioCardia | 15.29M |
| Akari Therapeutics, | 15.28M |